Cargando…
Cellular Therapies in Solid Organ Allotransplantation: Promise and Pitfalls
Donor specific transfusions have been the basis of tolerance inducing protocols since Peter Medawar showed that it was experimentally feasible in the 1950s. Though trials of cellular therapies have become increasingly common in solid organ transplantation, they have not become standard practice. Add...
Autores principales: | Shaw, Brian I., Ord, Jeffrey R., Nobuhara, Chloe, Luo, Xunrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435835/ https://www.ncbi.nlm.nih.gov/pubmed/34526991 http://dx.doi.org/10.3389/fimmu.2021.714723 |
Ejemplares similares
-
Mathematical Modeling of Early Cellular Innate and Adaptive Immune Responses to Ischemia/Reperfusion Injury and Solid Organ Allotransplantation
por: Day, Judy D., et al.
Publicado: (2015) -
Cellular activation pathways and interaction networks in vascularized composite allotransplantation
por: Knoedler, Leonard, et al.
Publicado: (2023) -
Innate Immunity and Resistance to Tolerogenesis in Allotransplantation
por: Benichou, Gilles, et al.
Publicado: (2012) -
Costimulation Blockade in Vascularized Composite Allotransplantation
por: Giannis, Dimitrios, et al.
Publicado: (2020) -
Sensitization and Desensitization in Vascularized Composite Allotransplantation
por: Moris, Dimitrios, et al.
Publicado: (2021)